RS
Rangoli Saurav Gada
About Rangoli Saurav Gada
Data last updated:
Rangoli Saurav Gada is a Director at Shine Pharmaceuticals Limited (since 2023), Director at Medicap Healthcare Limited (since 2024) and Director at Link Pharmachem Limited (since 2024). The companies operate in Pharma and Packaging. The 3 current companies with reported revenue have a combined latest revenue of ₹256 Cr; the largest is Shine Pharmaceuticals Limited at ₹120 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shine Pharmaceuticals Limited U24231GJ1994PLC022787 | Director | 25 Mar 2023 | 1994 | ₹120 Cr (FY 2025) | Active |
 Medicap Healthcare Limited U33309GJ2017PLC097697 | Director | 24 Dec 2024 | 2017 | ₹110 Cr (FY 2025) | Active |
 Link Pharmachem Limited L24230GJ1984PLC007540 | Director | 09 Aug 2024 | 1984 | ₹25.62 Cr (FY 2025) | Active |
Board colleagues of Rangoli Saurav Gada
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rangoli Saurav Gada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rangoli Saurav Gada
Rangoli Saurav Gada currently holds 3 directorships: Shine Pharmaceuticals Limited (Director, since 25 Mar 2023, revenue ₹120 Cr (FY 2025)); Medicap Healthcare Limited (Director, since 24 Dec 2024, revenue ₹110 Cr (FY 2025)); Link Pharmachem Limited (Director, since 09 Aug 2024, revenue ₹25.62 Cr (FY 2025)).
Rangoli Saurav Gada was first appointed on 25 Mar 2023 as Director at Shine Pharmaceuticals Limited. The most recent appointment on record is 24 Dec 2024 at Medicap Healthcare Limited.
The 3 current companies of Rangoli Saurav Gada that report revenue have a combined latest revenue of ₹256 Cr: Shine Pharmaceuticals Limited ₹120 Cr (FY 2025); Medicap Healthcare Limited ₹110 Cr (FY 2025); Link Pharmachem Limited ₹25.62 Cr (FY 2025).
The current boards of Rangoli Saurav Gada's companies include Aloka Saha (Shine Pharmaceuticals Limited), Hiranmay Saha (Shine Pharmaceuticals Limited), Pradeep Vishambhar Agrawal (Shine Pharmaceuticals Limited), Samir Chakraborty (Shine Pharmaceuticals Limited), Tejal Ashish Parikh (Shine Pharmaceuticals Limited), Bharat Chunilal Shah (Medicap Healthcare Limited), among others.